Pharma & Biotech

Assembly Biosciences shares continue to demonstrate impressive performance in the market, building on recent gains with strong technical indicators and...

Kura Oncology has achieved a significant regulatory milestone with the U.S. Food and Drug Administration granting full approval for its...

Altimmune finds itself at a critical juncture this quarter, with its shares potentially on the verge of a significant move....

The biotechnology sector has identified its latest standout performer: Axsome Therapeutics. This pharmaceutical firm is rapidly establishing itself as a...

The animal health sector's former high-flyer is confronting significant growth challenges. With market analysts systematically lowering their projections, the equity...

Scientific instrument manufacturer Bruker finds itself at a critical juncture. Despite delivering a quarterly earnings surprise, the company's stock faced...

Biogen has secured two significant advancements that could reinvigorate the biotechnology company's growth trajectory. Recent developments include a streamlined treatment...

Investors in Bristol-Myers Squibb encountered a significant market downturn as the pharmaceutical giant and its collaborator, Johnson & Johnson, terminated...

Investor attention is firmly fixed on Arrowhead Pharmaceuticals this week as the biotechnology firm approaches two significant milestones that could...

Eli Lilly shares are positioned for a strong week following two significant developments from opposite sides of the Atlantic. The...